Distributors Play a Role in Patient Access Programs
Biosimilar cost savings hinges on patient access. That’s why distributors—such as Cencora—work closely with biosimilar manufacturers to gain access to every biosimilar currently on the market in the United States, said Lakesha Farmer, Senior Director, Strategic Accounts, ION Oncology Practice Network at Cencora. “This ensures that our customers have access to every product that they need to provide their patients with these lower cost options,” she explained.
